Browse > Home / Archive by category 'FDA: MedWatch'

Drug Shortages: Current Drug Shortages; Alprostadil 0.5 mg/mL injection

December 9, 2008

Alprostadil 0.5 mg/mL injection: Teva Pharmaceuticals: Manufacturing delays; Bedford: Manufacturing delays; Pfizer, Inc.- Prostin VR pediatric Injection available from Pfizer

Written by FDA Drug Shortages · Filed Under FDA: MedWatch 

20 mEq Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP

December 9, 2008

Recall of one lot due to possible incorrect bar code for 5% Dextrose Injection, USP. The incorrect bar code could lead to a medication error resulting in the wrong drug being delivered to a patient if a bar code system is used to confirm the medication.

Written by FDA MedWatch · Filed Under FDA: MedWatch 

Terumo Cardiovascular Systems Tenderflow Pediatric Arterial Cannulae

December 8, 2008

Worldwide recall involving 21 lot codes, due to reports of difficulty retracting the introducer from the cannula.

Written by FDA MedWatch · Filed Under FDA: MedWatch 

Drug Shortages: Resolved Drug Shortages; MVI Adult Injectable

December 4, 2008

No further supply issues are anticipated

Written by FDA Drug Shortages · Filed Under FDA: MedWatch 

Drug Shortages: Resolved Drug Shortages; Methadone Hydrochloride Injection

December 3, 2008

No further supply issues are anticipated

Written by FDA Drug Shortages · Filed Under FDA: MedWatch 

Erythropoiesis Stimulating Agents (ESAs) - Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp)

December 2, 2008

(UPDATE) FDA issued Q and As for recently approved Medication Guides.

Written by FDA MedWatch · Filed Under FDA: MedWatch 

December 2008 Patient Safety News

December 1, 2008

Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.

Written by FDA MedWatch · Filed Under FDA: MedWatch 

Starcaps Dietary Supplement Capsules

November 26, 2008

Recall due to undeclared drug, Bumetanide, resulting in drug interactions including risk of hypotension (low blood pressure), or fainting (syncope).

Written by FDA MedWatch · Filed Under FDA: MedWatch 

Zhen De Shou Fat Loss Capsules

November 26, 2008

Recall due to undeclared sibutramine, an appetite suppressant known to substantially increase blood pressure and/or pulse rate in some patients.

Written by FDA MedWatch · Filed Under FDA: MedWatch 

Phenytoin (marketed as Dilantin, Phenytek and generics) and Fosphenytoin Sodium (marketed as Cerebyx and generics)

November 24, 2008

Potential increased risk of serious skin reactions, including Stevens Johnson syndrome and toxic epidermal necrolysis, from phenytoin therapy in Asian patients positive for a particular human leukocyte antigen allele, HLA-B*1502.

Written by FDA MedWatch · Filed Under FDA: MedWatch 

« Previous Page — Next Page »